BLUE SAIL MEDICAL(SZ:002382) Sou Hu Cai Jing·2026-01-15 13:23Core Viewpoint - Bluefan Medical (002382) has shown a slight increase in stock price, but the company is facing significant financial challenges, including declining revenues and profits [1][3]. Financial Performance - As of January 15, 2026, Bluefan Medical's stock closed at 6.03 yuan, with a 0.67% increase and a trading volume of 205,700 hands, amounting to a total transaction value of 125 million yuan [1]. - In the past five days, the company has experienced fluctuations in net capital flow, with a net inflow of 7.82 million yuan from main funds on January 15, 2026, which accounted for 6.24% of the total transaction value [2]. - The company's total market capitalization is 6.073 billion yuan, with a net asset value of 9.707 billion yuan, but it reported a net profit of -286 million yuan, ranking last in the industry [3]. Revenue and Profit Trends - For the first three quarters of 2025, Bluefan Medical reported a main revenue of 4.182 billion yuan, a year-on-year decrease of 10.15%, and a net profit attributable to shareholders of -286 million yuan, down 30.09% year-on-year [3]. - In Q3 2025 alone, the company recorded a main revenue of 1.401 billion yuan, a decline of 15.02% compared to the same quarter the previous year, and a net profit of -151 million yuan, a staggering drop of 153.64% [3]. Industry Comparison - Bluefan Medical's gross profit margin stands at 13.66%, significantly lower than the industry average of 50.62%, placing it in the 122nd position out of 126 companies in the medical device sector [3]. - The company's return on equity (ROE) is -3.56%, which is also below the industry average of 0.23%, ranking 119th out of 126 [3].